Former U.S. House Speaker Newt Gingrich (R-GA) is again highlighting the potential benefits of the powerful psychedelic ibogaine for people with serious mental and physical health conditions.
In an episode of his podcast Newt’s World, the former speaker spoke with the co-founders of Ambio Life Sciences, a company providing ibogaine treatment in Mexico.
Gingrich said the therapy option is at the “absolute cutting edge of science,” while inquiring about what makes ibogaine “such a uniquely powerful intervention” in the treatment of conditions like addiction.
He also noted that, while ibogaine is currently a Schedule I drug in the U.S. and cannot be accessed by most patients due to its lack of Food and Drug Administration (FDA) approval, aspirin is widely available even though it didn’t go through the rigorous regulatory approval process.
“We’ve grandfathered it in—and we can produce aspirin, and billions of people have taken it—but we literally could never meet the FDA standard,” he said.
“To what degree is the very complexity of ibogaine, when measured against what clearly is its impact, put in a kind of similar situation where we could spend so many years trying to figure out what the underlying mechanisms are—and we’re losing people
Read full article on Marijuana Moment
